Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Early Lung Decline Identified in Pulmonary Fibrosis
March 2026
Idiopathic pulmonary fibrosis progression may begin nearly a decade before symptoms, according to new modeling research.
Read more
14 Mar 2026
Early Lung Decline Identified in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis progression may begin nearly a decade before symptoms, according to new modeling research.
12 Mar 2026
Nerandomilast Shows Promise in Treating IIM-ILD
Nerandomilast reduced lung inflammation and fibrosis in IIM-ILD preclinical models. Read more to find out what this means for the future.
10 Mar 2026
Stem Cell Therapies Show Promise For Silicosis
STEM cell therapy is emerging as a promising approach for silicosis, an irreversible fibrotic lung disease caused by chronic exposure to respirable crystalline silica.
7 Mar 2026
Cardiorespiratory Fitness Linked to Lower COVID-19 Hospitalization
Higher cardiorespiratory fitness linked to lower COVID-19 hospitalization risk, but not SARS-CoV-2 infection, in a large population cohort.
5 Mar 2026
Obesity Hypoventilation Syndrome Treatment Improves Sleep
Obesity hypoventilation syndrome treatment improved as acetazolamide with atomoxetine reduced mean CO2 and AHI, raising saturation.
3 Mar 2026
Long COVID Drives Subchronic Lung and Brain Injury
A mouse long COVID model associates breathlessness with postinfectious fibrotic lung remodeling and neuroinflammation following clearance.
28 Feb 2026
Adult Asthma Morbidity Tied to Home Exposures
Statewide Texas survey data link indoor ventilation and smoking to higher adult asthma morbidity from 2019–2022.
26 Feb 2026
Sleep Apnea Hypoxic Burden Signals Postop Risk
Sleep apnea specific hypoxic burden predicted higher 30-day postoperative mortality and cardiac complications after major surgery.
Loading posts...
1
2
3
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View